SPRINGWORKS THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Class III Directors: Alan Fuhrman

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alan Fuhrman”): 43,174,031 for, 18,299,164 withheld, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 22,497,524 for, 5,679,222 withheld, 0 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Election of Class III Directors: Daniel S. Lynch, M.B.A.

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel S. Lynch, M.B.A.”): 57,963,373 for, 3,509,822 withheld, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 27,301,611 for, 875,135 withheld, 0 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Election of Class III Directors: Julie Hambleton, M.D.

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Julie Hambleton, M.D.”): 58,259,812 for, 3,213,383 withheld, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 27,378,439 for, 798,307 withheld, 0 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: A proposal to adopt the Agreement and Plan of Merger, dated as of April 27, 2025 (the "Merger Agreement"), by and among Merck KGaA, Darmstadt, Germany, a German corporation with general partners ("Parent"), EMD Holdings Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), and SpringWorks Therapeutics, Inc. (the "Company"), pursuant to which Merger Sub will be merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the "Merger").

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“1. The Merger Agreement Proposal Proposal 1 (the "Merger Agreement Proposal") was to consider and vote on a proposal to adopt the Merger Agreement”): 58,902,428 for, 89,192 against — passed, per its Form 8-K filed June 26, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 1: The Merger Agreement Proposal Proposal 1 (the "Merger Agreement Proposal") was to consider and vote on a proposal to adopt the Merger Agreement”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,578,903 for, 0 against, 0 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: A PROPOSAL TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES IN PERSON OR BY PROXY TO APPROVE THE PROPOSAL TO ADOPT THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING.

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Adjournment Proposal Proposal”): 54,818,866 for, 3,955,516 against — passed, per its Form 8-K filed June 26, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The results with respect to the Compensation Proposal are set forth below and the proposal was approved:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 69 asset managers below reported 19,178,543 for, 1,388,002 against, 5,796 abstained.

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

Description as filed by funds: Non-binding advisory vote on executive compensation

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“3. Non-Binding Advisory Vote on Executive Compensation”): 57,606,702 for, 3,851,046 against — passed, per its Form 8-K filed May 14, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 - Non-Binding Advisory Vote on Executive Compensation The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the annual meeting of stockholders.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 71 managers: 27,808,550 for, 359,681 against, 5,790 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 235 managers: 42,718,104 for, 2,751,100 against, 10,938 abstained, 32,661 not voted, 552,136 mixed. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: A proposal to approve, on a non- binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 69 managers: 18,604,453 for, 1,962,092 against, 5,796 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 188 managers: 31,919,575 for, 3,418,926 against, 147,900 abstained, 77,283 not voted. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 1 managers: 1,372 for.

Institutional-manager reports, all 3 managers: 516 for.

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as SpringWorks Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 66,999,344 for, 306,312 against — passed, per its Form 8-K filed May 14, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 28,238,351 for, 751 against, 5,790 abstained.

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.